Impello Biosciences is a biotechnology company that develops advanced medical devices and therapeutic solutions to improve patients' lives. They focus on innovative approaches in the fields of regenerative medicine, tissue engineering, and drug delivery.
Incorporated in 2015
Headquartered in San Francisco, California
Founded by a team of experienced scientists and engineers
Initially focused on developing tissue engineering solutions
Expanded their portfolio to include drug delivery systems
Received multiple grants and funding to support research and development
Collaborated with academic institutions and pharmaceutical companies
Organogenesis is a leading regenerative medicine company that develops and commercializes solutions for wound healing and tissue regeneration. They offer a wide range of products in various therapeutic areas.
Genentech is a biotechnology company specializing in the development and manufacturing of therapeutics. Their products include innovative treatments for cancer, autoimmune diseases, and other medical conditions.
Medtronic is a global medical technology company that offers a broad range of medical devices and therapies. They focus on areas such as cardiac and vascular health, diabetes management, and neurological disorders.
RegenFlow is a tissue engineering solution that facilitates the regeneration of damaged tissues and organs. It utilizes advanced biomaterials and growth factors to stimulate tissue regrowth.
DrugRelief is a novel drug delivery system that enables targeted and controlled release of therapeutics. It improves treatment efficacy and reduces side effects.
TheraPatch is a transdermal patch that delivers medications through the skin. It provides a non-invasive and convenient method of drug administration.
Impello Biosciences is known for developing innovative medical devices and therapeutic solutions using regenerative medicine and drug delivery technologies.
Some of the key products offered by Impello Biosciences include RegenFlow, DrugRelief, and TheraPatch.
Some of the competitors of Impello Biosciences include Organogenesis, Genentech, and Medtronic.
Impello Biosciences primarily focuses on tissue engineering, regenerative medicine, and drug delivery systems.
RegenFlow utilizes advanced biomaterials and growth factors to stimulate tissue regrowth, facilitating the regeneration of damaged tissues and organs.